-+ 0.00%
-+ 0.00%
-+ 0.00%

JIANGSU HENGRUI PHARMACEUTICALS <600276.SS> SAYS ITS SHR-4375 INJECTION FOR PANCREATIC CANCER GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA

路透·07/27/2026 08:44:25

登錄查看新聞詳情